Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
BioAge Labs
BioAge Labs

BioAge Labs

Series C

BioAge Labs builds software and services for its target customers and markets.

HQ
Richmond, CA, US
Founded
2015
Overview
Analysis
Compare
Fundraising
Employees
News

BioAge Labs develops technology products for organizations in its core market segment.

The company sells through direct channels and partnerships, serving customers with specialized workflows and operational needs.

BioAge Labs - Similar Companies

Wave Therapeutics logo

Wave Therapeutics

ConnectCareHero logo

ConnectCareHero

Lotus Labs logo

Lotus Labs

lotuslabs.org

Vivo logo

Vivo

teamvivo.com

Rezilient Health logo

Rezilient Health

Kinumi logo

Kinumi

kinumi.com

Rubitection logo

Rubitection

rubitection.com

MemoryWell logo

MemoryWell

Wysefit logo

Wysefit

wysefit.com

Tuktu Care logo

Tuktu Care

tuktu.ca

Zinnia Technologies logo

Zinnia Technologies

zinniatv.com

OndeCare logo

OndeCare

ondecare.com

Better Coliving logo

Better Coliving

Keep Company logo

Keep Company

keep-company.com

UpsideHoM logo

UpsideHoM

joinupside.com

BioAge Labs - Quick Facts

Who are BioAge Labs' competitors?

Companies similar to BioAge Labs include Wave Therapeutics, ConnectCareHero, Lotus Labs and Vivo.

When was BioAge Labs founded?

BioAge Labs was founded in 2015.

Where is BioAge Labs' headquarters located?

BioAge Labs' headquarters is located in Richmond, CA, US.

When was BioAge Labs' last funding round?

BioAge Labs' most recent funding round was for $90M (USD) in December 2020.

How much has BioAge Labs raised to-date?

As of Dec 3, 2020, BioAge Labs has raised a total of $123.9M (USD).

How many employees does BioAge Labs have?

BioAge Labs has 175 employees as of Feb 4, 2024.

BioAge Labs - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Development
Tags
  • Biotech
  • Healthtech
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software
Show 6 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7371Computer Programming Services